← Back to all recalls
DRUG RECALLMODERATE
Gemcitabine Injection
Hikma is recalling Gemcitabine Injection due to improper temperature storage.
What to do
Contact your healthcare provider or pharmacy if you have concerns about this medication. Do not use the affected product.
Recall at a glance
- Quantity recalled
- 74 units
Why it was recalled
Hikma is recalling Gemcitabine Injection due to temperature abuse. The product was stored in a controlled room temperature environment instead of the required refrigerated conditions.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Gemcitabine Injection, 1 g per 26.3 mL (
- Lot code
- CB0046, 2027
- Strength
- 38 mg
- NDC / UPC
- NDC 0143-9341-01
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
← Back to all recalls
Editorial summary by Recall Canary · summary updated 2026-07-22 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification